Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.
about
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detectionMicroRNA-145 targets YES and STAT1 in colon cancer cellsmiR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in miceUltra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controlsCooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseasesIdentification of non-coding RNAs embracing microRNA-143/145 clustermicroRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancerMicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTENMicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancerThe miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseasesAberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinomaHuman papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteinsmiR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancerThe miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease ProgressionExpression and Function of miR-155 in Diseases of the Gastrointestinal TractMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsImplications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesisThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisNon-coding RNAs in lung cancerMultistep model of cervical cancer: participation of miRNAs and coding genesMolecular mechanisms of HPV mediated neoplastic progressionCirculating microRNAs: potential biomarkers for common malignanciesUtility of microRNAs and siRNAs in cervical carcinogenesisEvaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic PotentialGene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancermiR-146a suppresses invasion of pancreatic cancer cellsmiR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cellsA putative role for microRNA-205 in mammary epithelial cell progenitorsmiR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J.A 3'-untranslated region (3'UTR) induces organ adhesion by regulating miR-199a* functions.Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.Single-nucleotide polymorphisms among microRNA: big effects on cancer.Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a.Screening candidate microRNAs (miRNAs) in different lambskin hair follicles in Hu sheep.MicroRNA expression variability in human cervical tissuesTranscript levels of ten-eleven translocation type 1-3 in cervical cancer and non-cancerous cervical tissues.Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesionsMicroRNA-326 suppresses the proliferation, migration and invasion of cervical cancer cells by targeting ELK1Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer.
P2860
Q21134914-F3EBC677-8670-4D09-8C10-B774D81D1AEDQ21142669-5D33DF09-38F5-415B-8CE3-4104B3378C31Q21142723-FA4CFB11-6895-4B1C-8B6D-2F630A55E76CQ21245318-2480919E-0C29-43F2-BFD9-A09AD39CDFB7Q21245705-E446408D-B063-411C-B440-53DD211D4A2BQ21245713-CFE8499D-F4B0-4C88-A49A-8543BC4334C8Q24299080-3D5E67C0-8701-4366-8F80-5C2DDCD9AC80Q24597730-22032460-6434-4F92-B89F-7FF7BFCA171BQ24603354-97D5DB04-36AC-4EBD-99BD-1CABA1EA04D8Q24608620-FD73CBB7-33E2-40A8-A21A-04443F18C6CAQ24627680-C5FAA09E-9565-4B0E-B9F7-0EFFCFAA3C67Q24629203-117EE8AC-0F59-4FA4-8E26-59E3E5D28755Q24632886-4C0FE65B-30BE-4533-BE98-D5F3E6B31603Q26744831-255F2EC0-A21E-46E4-9D46-212BA5C6F617Q26749058-36AEB9A8-53B4-41AD-874F-CA0CE2F027D2Q26773183-4B2325DD-D1F3-429E-880E-3F6CABF2E8FDQ26783563-9ACBB587-A9CC-47B9-86FB-95BDF30C5EE9Q26800055-42C2DB05-8AAB-4292-BAF0-DBB472DCF176Q26866521-A5792512-E9BD-428F-8949-C5608B3753C3Q27001000-887535D4-A67D-41CE-A021-4D50DE04AFECQ28070323-E341C91E-7F3C-4519-BA5E-3D5494FB480DQ28081347-AC83C271-312B-427C-8954-D9C732E86B43Q28083010-9F94AA90-6889-44B8-B384-2191D9AFF0E2Q28084310-F18505CF-D936-4864-B349-B6A5E235E52AQ28119171-A95CC93C-6629-4D44-B032-D8B3D7299C7BQ28272101-690A9AAD-D029-49B8-87A1-ED345B8C81E9Q28473023-7DF47DEA-D964-4323-8F99-EC7092F3BF66Q28595079-F3BC98A0-920F-4CD1-AFE5-A0E522C996F9Q31145646-FB5F349D-6FB6-49F2-A39F-7C9DC9688B89Q32182056-29FB2DEE-B404-4B61-98BC-AE26ECCDC27CQ33410103-C2248D6C-8689-4C55-8ABE-6C1565C26455Q33432690-431D50E2-D2B0-4CD9-9731-5D1A4DB941DEQ33579702-F2928156-5AF8-48EC-97F5-9A0DFB62AA6BQ33582905-072E1461-2738-466D-9D34-0930E5424AB8Q33626735-53C35E1E-0B06-4552-90FC-C98252D3070EQ33644448-61843F13-9B9D-4308-87BF-45031C878C86Q33684827-88847AAF-CC80-41DC-A5CF-23302786DBAEQ33685531-D3058FFF-0521-4133-9EBA-34DFCE26310AQ33685995-9F67C419-0811-4D2C-AB7E-B4FD4F32CF6DQ33688159-BA87BE8A-710E-41F1-A5EA-EFB7C9F357F9
P2860
Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Aberrant expression of oncogen ...... quired for cancer cell growth.
@ast
Aberrant expression of oncogen ...... quired for cancer cell growth.
@en
type
label
Aberrant expression of oncogen ...... quired for cancer cell growth.
@ast
Aberrant expression of oncogen ...... quired for cancer cell growth.
@en
prefLabel
Aberrant expression of oncogen ...... quired for cancer cell growth.
@ast
Aberrant expression of oncogen ...... quired for cancer cell growth.
@en
P2093
P2860
P1433
P1476
Aberrant expression of oncogen ...... quired for cancer cell growth.
@en
P2093
Craig Meyers
Janet S Rader
Shu-Yun Le
Shuang Tang
Xiaohong Wang
Zhi-Ming Zheng
P2860
P356
10.1371/JOURNAL.PONE.0002557
P407
P577
2008-07-02T00:00:00Z